Skip to main content

New Chief Business Officer at Precirix

  • January 11, 2021

VUB spin-off Precirix, a private, clinical-stage biotechnology company developing novel radiopharmaceuticals in oncology, announces the appointment of Dr. Niva Almaula, an experienced business development executive based in New York, as Chief Business Officer. In this role, Dr. Almaula will drive the company’s global business development strategy.

Read more